A Study of ORX142 in Healthy Adult Subjects, Including Subjects 18 to 80 Years of Age
ConditionExcessive Daytime Sleepiness
Trial statusRecruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age18-80
SponsorCentessa Pharmaceuticals (UK) Limited